The Big3Bio Event Preview – EPPICon 2016

Home/Spotlights/The Big3Bio Event Preview – EPPICon 2016

The Big3Bio Event Preview – EPPICon 2016

It all begins with accurate diagnostics.

Discovery of accurate biomarkers triggers the development of new therapeutic drugs as well as companion patient side diagnostic tools, and advances and miniaturization in digital health technology are now leading the democratization of diagnostics by placing these critical tools in the form of wearables and cloud-connected home devices in the hands of end users. With an increasing emphasis on personalized medicine and targeted therapies, diagnostics and biomarkers are playing an important role in drug discovery and development.

Now, more than ever, is the time for EPPICon 2016 – the annual content-rich conference that will have brilliant speakers and invigorating panel discussions about this “3D” era in the industry: The convergence of drug discovery, diagnostics and digital health.

EPPICon_2015 (6)

From EPPICon 2015

From the opening keynote by James Sabry of Genentech to the closing keynote by CLSA CEO, Sara Radcliffe, EPPICon 2016 will present an entire day of programming on hot topics related to the development of drugs, diagnostics and digital health. In keeping with the tradition of EPPICon, the organizing committee has invited thought leaders that are shaping the future of the life science industry through technological innovation. There will be time to jostle around ideas, meet individuals about investment opportunities and form new alliances.

Download Flyer

FULL AGENDA FOR EPPICON 2016

Conference Agenda
Registration / Breakfast and Networking
Welcome Address: Chitra Sharma, President, EPPIC Global
Opening / Plenary Keynote: James Sabry – Genentech
Panel 1: Drug Development
» Paul Hastings – Oncomed
» Carlos Garcia – Gilead
» Anil Singhal – AbbVie
Panel 2: Digital Health
» Jack Lloyd, Inventor (Nellcor & Humphrey Instruments)
» Gregg Jackson, ProPharma Group
» Ben Dubin, Asset Management Ventures
Lunch (Speed Network open)
Conference Remarks: Anjali Pandey, Co Chair, EPPICon 2016
Panel 3: Diagnostics
» Catherine Mohr, Intuitive Surgical
» Mohan Iyer, Second Genome
» Ramesh Hariharan, BioTheranostics
» Ravi Srinivasan, OncoNano & Corium
Panel 4: Speed Pitch
Speed Pitch: Entrepreneurs in Life sciences pitch their ideas to seasoned investors – a unique opportunity for symbiosis of ideas and investments
» Ajit Singh, Artiman Ventures
» Ben Dubin, Asset Management Ventures
» Faz Bashi, Angel Capital Association
» Alex Nie, Sheppard Mullin
» Adam de la Zerde, Click Diagnostics
Closing Keynote: Sara Radcliffe, California Life Sciences Association
Closing Remarks: Amita Goel, Co-Chair, EPPICon 2016
Evening Reception and Networking
 

Register Now: https://www.123signup.com/register?id=ppjrk

Event Co-Chairs:
Amita Goel, Founder, Celltheon Corporation and Dr. Anjali Pandey, SVP, Portola Pharmaceuticals
eppiccs

 


 

 

More about EPPIC from website:


“EPPIC was founded on March 4, 1998, by a group of Silicon Valley life science professionals who shared both a passion for their industry and a common heritage from the Indian subcontinent. EPPIC’s mission is to promote networking, entrepreneurship and mentoring for life science professionals, create US-India life science synergy, and be a resource for industry and academia.

EPPIC is an entirely volunteer-driven non-profit organization run by individuals passionate about making a difference. EPPIC has a number of illustrious scientists and industry leaders as active members who are in synch with the latest ideas, trends, needs and drive the organization’s mission. EPPIC has organized more than 50 quarterly networking events and seven annual conferences for the benefit of the life science community, not to mention the numerous start ups and longstanding mentoring relationships that have blossomed out of EPPIC meetings. Industry leaders have endorsed EPPIC events for rich and meaningful science and engineering content and the valuable networking opportunities that EPPIC events create. EPPIC membership is open to all professionals interested in all sectors and functions in the life science industry.”

Full website information

Frequently Asked Questions »

  • What do your attendees gain out of attending this event?
  • How and when was EPPIC started?
  • What is EPPIC’s philosophical base?
  • Is EPPIC a venture/investment organization?
  • What are EPPIC’s accomplishments?
  • How is EPPIC helping the other regions of the world?
  • What are EPPIC’s long-term goals? What is the future of EPPIC? 


What do your attendees gain out of attending this event?

Untitled

Chitra Sharma, President, EPPIC Global

This conference will cover discovery of accurate biomarkers triggers the development of new therapeutic drugs as well as companion patient side diagnostic tools. In addition, advances and miniaturization in digital health technology are now leading the democratization of diagnostics by placing these critical tools in the form of wearables and cloud-connected home devices in the hands of end users. All the attendees will be able to learn about latest ideas, needs of the Silicon Valley biotech community, meet most popular key leaders, mentors of the industry, present their start-up ideas of their companies, and become a members of EPPIC organization.


How and when was EPPIC started?

The concept of EPPIC was born at the middle of 1998. The idea originated with the objective of sharing and giving back to society. Initially a small group of individuals launched EPPIC with quarterly dinner meetings, which, in turn, attracted more members. EPPIC remains a unique volunteer driven organization, with the single-minded focus on its objective.


What is EPPIC’s philosophical base?

EPPIC’s philosophical base is a compatible blend of the Silicon Valley culture of economic value creation through Entrepreneurship, and the ancient Indian tradition of Guru / Shishya or Teacher / Disciple relationship. This enables very productive networking and mentoring relationships among and between experienced and budding entrepreneurs and professionals through the two-way exchange of value in experience and knowledge.

EPPIC’s Philosophical Framework  is to:

  • Create an open, inclusive, and transparent organization
  • Provide positive leadership role models
  • Emphasize value-creation through informed entrepreneurship
  • Maintain high ethical standards
  • Display rigorous, intellectually honest behavior
  • Pursue a modern, scientific and forward looking approach
  • Remain socially responsible
  • Do not tolerate pettiness, divisiveness and corruption
  • Strive to remain an idea and value-driven organization

Is EPPIC a venture/investment organization?

No! EPPIC is not a venture/investments organization. However, EPPIC members, through their network relationships, often invest in companies with EPPIC affiliations. EPPIC also does not endorse any investments, even though companies are presented at EPPIC events. EPPIC has facilitated venture investment by providing a platform for entrepreneurs and VC funds to come together.


What are EPPIC’s accomplishments?

In addition to the impressive membership, we believe we have a number of achievements to our credit. By facilitating ideas to germinate into actual businesses, EPPIC has created wealth and helped boost the global economy. With EPPIC’s continued growth we are confident that this figure will continue to increase. Also, we strive to proactively initiate new programs to give value to all our constituent members.


What are EPPIC’s long-term goals? What is the future of EPPIC?

EPPIC aspires to continue the expansion of its chapters and membership worldwide, while maintaining a clear focus on its objectives and philosophies. EPPIC will therefore continue to encourage and support the efforts and spirit of entrepreneurship everywhere. EPPIC aims to continue its pivotal role in the formulation of sound ecosystems for regional and national economic growth through private enterprise.

EPPIC has access to a large pool of intellectual capital and would like to leverage this to influence public policy around the world. The objective is to create wealth by creating an environment for establishing global businesses.

 

March 6th, 2016|

Leave A Comment

X